tiprankstipranks
Trending News
More News >
Merus NV (MRUS)
NASDAQ:MRUS
US Market
Advertisement

Merus (MRUS) Drug Pipeline

Compare
491 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Pembrolizumab, Petosemtamab
Head And Neck Squamous Cell Carcinoma
Phase III
Recruiting
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Jul 24, 2024
Petosemtamab, Investigator's Choice
Head And Neck Squamous Cell Carcinoma
Phase III
Recruiting
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
Jul 03, 2024
Afatinib Oral Tablet, Enzalutamide Pill, Abiraterone Acetate Tablets, Mcla-128
Metastatic Castration-Resistant Prostate Cancer, Nsclc Harboring Nrg1 Fusion
Phase II
Active Not Recruiting
Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers
Oct 14, 2022
Chemotherapy, Osimertinib, Mcla-129
Colorectal Cancer, Gastric Cancer, Head And Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase I/II
Recruiting
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
Apr 09, 2021
Mcla-145, Pembrolizumab (Keytruda)
Advanced Cancer, Solid Tumor, Adult, B-Cell Lymphoma, Adult
Phase I
Completed
A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies
Apr 15, 2019
Mcla-158, Mcla-158 + Pembrolizumab, Mcla-158 + Folfiri, Mcla-158 + Folfox
Colorectal Cancer, Gastric Cancer, Esophageal Cancer, Head And Neck Squamous Cell Carcinoma, Nsclc, Hnscc, Advanced/Metastatic Solid Tumors, Gastroesophageal-Junction Cancer
Phase I/II
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Apr 04, 2018
Vinorelbine, Trastuzumab, Endocrine Therapy, Zenocutuzumab
Breast Cancer Metastatic
Phase II
Completed
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.
Oct 11, 2017
Mcla-117 Bispecific Antibody
Acute Myeloid Leukemia, Acute Myelogenous Leukemia
Phase I
Terminated
MCLA-117 in Acute Myelogenous Leukemia
Jan 26, 2017

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Merus NV (MRUS) have in its pipeline
      MRUS is currently developing the following drugs: Pembrolizumab, Petosemtamab, Petosemtamab, Investigator's Choice, Afatinib Oral Tablet, Enzalutamide Pill, Abiraterone Acetate Tablets, Mcla-128. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis